|
Market Closed -
Euronext Bruxelles
11:55:00 2026-11-11 EST
|
5-day change | 1st Jan Change | ||
| 291.30 EUR | -1.09% |
|
+3.08% | +22.09% |
| 11-09 | UCB Announces Week 24 Data For BIMZELX Bimekizumab-Bkzx From BE BOLD Study | CI |
| 11-09 | UCB And Biogen Announce Clinical Profile Data For Dapirolizumab Pegol In Systemic Lupus Erythematosus | CI |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
